Education
About Us
Working with TipRanks
Follow Us
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 146.07M | $ 145.24M | $ 146.03M | $ 157.07M | $ 209.82M |
| Gross Profit | $ 140.12M | $ 139.23M | $ 141.09M | $ 151.86M | $ 206.42M |
| Operating Income | $ -90.71M | $ -119.44M | $ -129.54M | $ -142.20M | $ -98.27M |
| EBITDA | $ -90.41M | $ -38.60M | $ -118.42M | $ -139.31M | $ -96.98M |
| Net Income | $ -196.04M | $ -76.42M | $ -143.10M | $ -165.29M | $ -124.09M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 63.74M | $ 108.71M | $ 191.44M | $ 277.97M | $ 228.62M |
| Total Assets | $ 108.42M | $ 164.42M | $ 240.44M | $ 358.17M | $ 305.31M |
| Total Debt | $ 233.61M | $ 194.52M | $ 177.02M | $ 179.07M | $ 180.58M |
| Net Debt | $ 173.07M | $ 132.05M | $ 124.78M | $ 43.89M | $ -9.88M |
| Total Liabilities | $ 401.34M | $ 350.44M | $ 376.64M | $ 374.83M | $ 384.98M |
| Stockholders' Equity | $ -292.93M | $ -186.02M | $ -136.21M | $ -16.66M | $ -79.67M |
| Cash Flow | |||||
| Free Cash Flow | $ -75.37M | $ -127.63M | $ -92.72M | $ -149.67M | $ -112.83M |
| Operating Cash Flow | $ -75.37M | $ -127.49M | $ -92.72M | $ -149.55M | $ -107.12M |
| Investing Cash Flow | $ 43.38M | $ 95.47M | $ 7.94M | $ -104.26M | $ 141.84M |
| Financing Cash Flow | $ 30.05M | $ 41.65M | $ 1.12M | $ 193.74M | $ 73.65M |